Loading...
Xywav And Epidiolex Will Expand CNS And Orphan Markets
n/a
n/a
AnalystHighTarget's Fair Value
n/a
1Y
42.3%7D
4.0%1Y
42.3%7D
4.0%You can edit this narrative until May 12 6:02 AM. Then, changes will post as Updates.
You can edit this narrative until May 12 6:02 AM. Then, changes will post as Updates.